Logo image of ADOC

EDOC ACQUISITION CORP-CL A (ADOC) Stock Fundamental Analysis

NASDAQ:ADOC - Nasdaq - KYG4000A1022 - Common Stock - Currency: USD

2.85  -5.17 (-64.46%)

After market: 2.99 +0.14 (+4.91%)

Fundamental Rating

0

Taking everything into account, ADOC scores 0 out of 10 in our fundamental rating. ADOC was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of ADOC have multiple concerns. ADOC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ADOC had negative earnings in the past year.
In the past year ADOC has reported a negative cash flow from operations.
ADOC Yearly Net Income VS EBIT VS OCF VS FCFADOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -21%
ROE -61.4%
ROIC N/A
ROA(3y)-12.5%
ROA(5y)N/A
ROE(3y)-15.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADOC Yearly ROA, ROE, ROICADOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADOC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADOC Yearly Profit, Operating, Gross MarginsADOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ADOC has less shares outstanding
The debt/assets ratio for ADOC is higher compared to a year ago.
ADOC Yearly Shares OutstandingADOC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2M 4M 6M 8M 10M
ADOC Yearly Total Debt VS Total AssetsADOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

ADOC has an Altman-Z score of -1.94. This is a bad value and indicates that ADOC is not financially healthy and even has some risk of bankruptcy.
ADOC has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z -1.94
ROIC/WACCN/A
WACCN/A
ADOC Yearly LT Debt VS Equity VS FCFADOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.01 indicates that ADOC may have some problems paying its short term obligations.
ADOC has a Quick Ratio of 0.01. This is a bad value and indicates that ADOC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ADOC Yearly Current Assets VS Current LiabilitesADOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

ADOC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.55%, which is quite impressive.
EPS 1Y (TTM)60.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.02%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ADOC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADOC Price Earnings VS Forward Price EarningsADOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADOC Per share dataADOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ADOC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDOC ACQUISITION CORP-CL A

NASDAQ:ADOC (3/21/2024, 8:09:40 PM)

After market: 2.99 +0.14 (+4.91%)

2.85

-5.17 (-64.46%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-01 2023-12-01
Earnings (Next)N/A N/A
Inst Owners3.9%
Inst Owner Change0%
Ins Owners11.44%
Ins Owner Change0%
Market Cap10.32M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS0.9
TBVpS0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21%
ROE -61.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.5%
ROA(5y)N/A
ROE(3y)-15.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.94
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.09%
OCF growth 3YN/A
OCF growth 5YN/A